Sugi Predict

Sugi Predict / Compounds / SCHEMBL11230405

SCHEMBL11230405

SCHEMBL11230405

O=C(c1ccccc1)c1ccc([N+](=O)[O-])cc1[N+](=O)[O-]

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.75
▸ ALDH1A1 P00352 5/20 0.61
▸ LMNA P02545 4/20 0.57
▸ POLB P06746 3/20 0.57
▸ MAPT P10636 3/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ HTT P42858 1/20 0.57
▸ KMT2A Q03164 3/20 0.54
▸ GAA P10253 1/20 0.53
▸ CES1 P23141 1/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ TP53 P04637 2/20 0.51
▸ VCAM1 P19320 1/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ HPGD P15428 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ GPR35 Q9HC97 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP19A1 P11511 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29355334 1.00 CES2 (0.75) CES2ALDH1A1LMNAPOLBMAPT
Hydrazine SCHEMBL28178906 0.97 CES2 (0.71) CES2ALDH1A1LMNAPOLBMAPT
SCHEMBL28066803 0.86 ALDH1A1 (0.68) CES2ALDH1A1LMNAPOLBMAPT
SCHEMBL5341177 0.86 CES2 (0.63) CES2ALDH1A1POLBMAPTSMN1; SMN2
SCHEMBL2157550 0.86 CES2 (1.00) CES2ALDH1A1LMNAPOLBMAPT
SCHEMBL27605266 0.85 CES2 (0.72) CES2ALDH1A1LMNAPOLBMAPT
SCHEMBL9816327 0.84 CES2 (0.55) CES2ALDH1A1LMNAPOLBMAPT
SCHEMBL27605479 0.84 CASP6 (0.62) CES2ALDH1A1LMNAPOLBMAPK1
SCHEMBL11010668 0.84 LMNA (0.60) CES2ALDH1A1LMNAPOLBMAPT
SCHEMBL5313439 0.84 MAPT (0.60) CES2ALDH1A1LMNAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113972343-B Quantum dot light emitting diode and preparation method thereof TCL科技集团股份有限公司 2024-05-24 — — CN claimed
US-12568731-B2 Quantum dot film, method for preparing the same, and quantum dot light emitting diode TCL TECHNOLOGY GROUP CORPORATION (CN) 2026-03-03 — — US disclosed
CN-113972343-B Quantum dot light emitting diode and preparation method thereof TCL科技集团股份有限公司 2024-05-24 — — CN disclosed
CN-113972342-B Quantum dot film and preparation method thereof, and quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2024-04-30 — — CN disclosed
US-20230023840-A1 QUANTUM DOT FILM, METHOD FOR PREPARING THE SAME, AND QUANTUM DOT LIGHT EMITTING DIODE TCL TECHNOLOGY GROUP CORPORATION (CN) 2023-01-26 — — US disclosed
WO-2022016822-A1 QUANTUM DOT LIGHT-EMITTING DIODE AND PREPARATION METHOD THEREFOR TCL科技集团股份有限公司 2022-01-27 — — WO disclosed
WO-2022016821-A1 QUANTUM DOT THIN FILM AND MANUFACTURING METHOD THEREFOR, AND QUANTUM DOT LIGHT EMITTING DIODE TCL科技集团股份有限公司 2022-01-27 — — WO disclosed
WO-2022016820-A1 QUANTUM DOT LIGHT-EMITTING DIODE AND PREPARATION METHOD THEREFOR TCL科技集团股份有限公司 2022-01-27 — — WO disclosed
CN-113972342-A Quantum dot film and preparation method thereof, and quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-01-25 — — CN disclosed
CN-113972345-A Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-01-25 — — CN disclosed
CN-108025089-A Oligonucleotide composition and its method 波涛生命科学有限公司 2018-05-11 — — CN disclosed
CN-107254513-A It is used for the composition and method for detecting chromosome aberration using new hybridization buffer 丹麦达科有限公司 2017-10-17 — — CN disclosed
CN-103664911-B The method for preparing vilazodone and its intermediate 江苏先声药业有限公司 2017-09-15 — — CN disclosed
CN-103570697-B The method for preparing vilazodone and its intermediate 江苏先声药业有限公司 2017-09-15 — — CN disclosed
CN-107043339-A New cross-linking reagent, macromolecular, treatment conjugate and its synthetic method 希默赛生物技术有限责任公司 2017-08-15 — — CN disclosed
CN-102046808-B Compositions and methods for detecting chromosomal aberrations using novel hybridization buffers 丹麦达科有限公司 2017-05-17 — — CN disclosed
CN-104066451-B Novel cross-linking reagents, macromolecules, therapeutic conjugates and methods for their synthesis 希默赛生物技术有限责任公司 2017-04-05 — — CN disclosed
CN-106470975-A Synthesis of Polycyclic Carbamoylpyridone Compounds 吉利德科学公司 2017-03-01 — — CN disclosed
CN-106068325-A CHIRAL DESIGN 波涛生命科学有限公司 2016-11-02 — — CN disclosed
US-4347383-A BY REACTING BENZOPHENONE-IMINE WITH OXYGEN OR BENZOPHENONE WITH OXYGEN AND AMMONIA MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1982-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12568731-B2 Quantum dot film, method for preparing the same, and quantum dot light emitting diode TERT, CRYAA, VCL CES2 1145/4885ALDH1A1 801/4885LMNA 1915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.